To explore the potential effect of circRNAs on post-transplant relapse, we first performed RNA-seq on purified BM CD34+ cells from AML patients who received first allo-HSCT (CR and RE, N = five per group) and healthy controls (HC, N = four) in the discovery set (Figure 1). Here, CD34 is linked to acute myeloid leukemia.